| PERIOD ENDING | 31-Mar-09 | 31-Dec-08 | 30-Sep-08 | 30-Jun-08 | | Total Revenue | 831,600 | 1,112,700 | 1,392,400 | 1,461,200 | | Cost of Revenue | 750,900 | 890,300 | 1,085,800 | 1,128,900 | | | Gross Profit | 80,700 | 222,400 | 306,600 | 332,300 | | | Operating Expenses | | Research Development |
-
|
-
|
-
|
-
| | Selling General and Administrative | 80,800 | 59,000 | 74,300 | 79,200 | | Non Recurring |
-
|
-
|
-
|
-
| | Others |
-
|
-
|
-
|
-
| | | | Total Operating Expenses |
-
|
-
|
-
|
-
| | | | Operating Income or Loss | (100) | 163,400 | 232,300 | 253,100 | | | Income from Continuing Operations | | Total Other Income/Expenses Net | 500 | 7,000 | (2,600) | (1,900) | | Earnings Before Interest And Taxes | 400 | 162,800 | 229,700 | 251,200 | | Interest Expense | 100 | 700 | 1,700 | 1,100 | | Income Before Tax | 300 | 162,100 | 228,000 | 250,100 | | Income Tax Expense | (5,000) | 51,200 | 83,900 | 81,200 | | Minority Interest |
-
| (7,600) |
-
|
-
| | | | Net Income From Continuing Ops | 5,300 | 110,900 | 144,100 | 168,900 | | | Non-recurring Events | | Discontinued Operations |
-
|
-
|
-
|
-
| | Extraordinary Items |
-
|
-
|
-
|
-
| | Effect Of Accounting Changes |
-
|
-
|
-
|
-
| | Other Items |
-
|
-
|
-
|
-
| | | | Net Income | 5,300 | 110,900 | 144,100 | 168,900 | | Preferred Stock And Other Adjustments | 600 |
-
|
-
|
-
| | | Net Income Applicable To Common Shares | $5,900 | $110,900 | $144,100 | $168,900 |
|
0.45% Nasdaq 
0.20%
Income Statement
